Selective Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,600
Closed -$205K 109
2025
Q3
$205K Sell
4,600
-201
-4% -$9.39K 0.07% 99
2025
Q2
$229K Sell
4,801
-800
-14% -$39.3K 0.08% 93
2025
Q1
$284K Sell
5,601
-111
-2% -$6.47K 0.12% 78
2024
Q4
$318K Sell
5,712
-2,122
-27% -$119K 0.13% 73
2024
Q3
$411K Sell
7,834
-179
-2% -$8.4K 0.17% 65
2024
Q2
$327K Sell
8,013
-41
-0.5% -$1.83K 0.14% 76
2024
Q1
$405K Sell
8,054
-200
-2% -$10.2K 0.18% 69
2023
Q4
$430K Sell
8,254
-928
-10% -$48.7K 0.22% 51
2023
Q3
$521K Sell
9,182
-1,469
-14% -$90K 0.29% 40
2023
Q2
$665K Buy
+10,651
New +$714K 0.33% 39
2022
Q4
$848K Sell
11,433
-5,400
-32% -$407K 0.45% 35
2022
Q3
$1.2M Sell
16,833
-11,323
-40% -$821K 0.51% 33
2022
Q2
$2.17M Sell
28,156
-85
-0.3% -$6.47K 0.77% 27
2022
Q1
$2.06M Sell
28,241
-1,790
-6% -$120K 0.75% 23
2021
Q4
$1.87M Sell
30,031
-335
-1% -$19.7K 0.76% 24
2021
Q3
$1.8M Sell
30,366
-14,100
-32% -$929K 0.95% 21
2021
Q2
$2.97M Sell
44,466
-15,035
-25% -$980K 2.37% 8
2021
Q1
$3.76M Sell
59,501
-9,295
-14% -$578K 3.42% 8
2020
Q4
$4.27M Buy
68,796
+9,454
+16% +$581K 2.76% 10
2020
Q3
$3.58M Buy
59,342
+855
+1% +$51.5K 2.81% 10
2020
Q2
$3.44M Buy
58,487
+55,804
+2,080% +$3.34M 2.85% 10
2020
Q1
$150K Buy
2,683
+4
+0.1% +$244 0.23% 30
2019
Q4
$172K Sell
2,679
-106
-4% -$6.07K 0.21% 35
2019
Q3
$141K Buy
+2,785
New +$131K 0.19% 42
2018
Q3
$184K Buy
+2,970
New +$176K 2.2% 15

Other funds holding BMY

Selective Wealth Management's BMY Position: Q4 2025 in Review

Selective Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 4,600 shares — an estimated $205K sold.

Selective Wealth Management first reported a position in BMY in Q3 2018 and held it in 25 quarters. The position peaked at $4.27M in Q4 2020. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Selective Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Selective Wealth Management sold 4,600 Bristol-Myers Squibb shares in Q4 2025, an estimated $205K.
  • Selective Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2018 and held it in 25 quarters.
  • Selective Wealth Management's Bristol-Myers Squibb position peaked at $4.27M in Q4 2020.
  • 2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Selective Wealth Management's 13F filing for Q4 2025, filed 16 Jan 2026.